CTA
TNDM icon

Carillon Tower Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Carillon Tower Advisers’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$29.4M Sell
306,933
-4,962
-2% -$511K 0.18% 174
2020
Q3 		$35.4M Sell
311,895
-147,020
-32% -$15.4M 0.47% 50
2020
Q2 		$45.4M Sell
458,915
-303,632
-40% -$24.2M 0.35% 95
2020
Q1 		$46.1M Buy
762,547
+53,528
+8% +$3.75M 0.45% 62
2019
Q4 		$42.3M Hold
709,019
– – 0.28% 127
2019
Q3 		$41.8M Hold
709,019
– – 0.29% 125
2019
Q2 		$45.7M Sell
709,019
-213,716
-23% -$13.8M 0.31% 111
2019
Q1 		$58.6M Buy
922,735
+190,728
+26% +$10M 0.41% 76
2018
Q4 		$27.8M Hold
732,007
– – 0.24% 168
2018
Q3 		$31.4M Buy
+732,007
New +$25.6M 0.22% 172

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return